Cimetidine Hydrochloride
The hydrochloride salt formulation of cimetidine is used for parenteral administration in hospitalized patients requiring acid suppression. It shares the same H2 receptor blocking activity and drug interaction profile as the oral form. Gynecomastia and other anti-androgenic effects have been noted with higher doses due to its weak androgen receptor antagonism.
Khối lượng phân tử
288,8000 g/mol
TPSA
114,00 Ų
Cơ chế tác dụng
Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) on the apical surface of gastric parietal cells. This blocks the final common pathway of gastric acid secretion, producing profound and sustained acid suppression.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) on the apical surface of gastric parietal cells. This blocks the final common pathway of gastric acid secretion, producing profound and sustained acid …
Cấu trúc 2D
Cite this structure
Embed this structure
SMILES
CN/C(=N\CCSCc1nc[nH]c1C)NC#N.Cl
InChI
InChI=1S/C10H16N6S.ClH/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11;/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14);1H
Molecular Formula
C10H17ClN6S
HBD / HBA
4 / 4
Liên kết có thể quay
7
Nguyên tử nặng
18
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Câu hỏi thường gặp
The hydrochloride salt formulation of cimetidine is used for parenteral administration in hospitalized patients requiring acid suppression. It shares the same H2 receptor blocking activity and drug interaction profile as the oral form. Gynecomastia and other anti-androgenic effects have been noted with higher doses due to its weak androgen receptor antagonism.
Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) on the apical surface of gastric parietal cells. This blocks the final common pathway of gastric acid secretion, producing profound and sustained acid suppression.
Yes, Cimetidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201051. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 50963. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="cimetidine-hydrochloride"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/cimetidine-hydrochloride/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/cimetidine-hydrochloride/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/cimetidine-hydrochloride/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="cimetidine-hydrochloride"></drugfyi-drug>